Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor targeting by an aptamer.

Brian J Hicke1, Andrew W Stephens, Ty Gould

  • 1NeXstar Pharmaceuticals, Boulder, Colorado, USA. bhicke@gmail.com

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|April 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Hemopericardium Due to Atrioventricular Disruption After Mitral Valve Replacement With Nonemergent Left Ventricular Pseudoaneurysm Repair.

Annals of thoracic surgery short reports·2026
Same author

Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophy.

European journal of nuclear medicine and molecular imaging·2026
Same author

A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.

Alzheimer's research & therapy·2026
Same author

In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences.

Alzheimer's research & therapy·2026
Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
See all related articles

Aptamers like TTA1 show promise for in vivo cancer imaging and therapy. This study demonstrates rapid tumor uptake and clearance, enabling clear visualization of tumors for potential diagnostic and therapeutic applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Oncology

Background:

  • Aptamers are selected oligonucleotides with high specificity for target molecules.
  • Their potential for in vivo delivery of radioisotopes or cytotoxic agents requires investigation.

Purpose of the Study:

  • To evaluate the in vivo delivery potential of aptamers for radioisotope or cytotoxic agent delivery.
  • To assess the biodistribution and tumor uptake of TTA1, an aptamer targeting tenascin-C.

Main Methods:

  • TTA1 aptamer was labeled with fluorescent and radiolabeled forms (99mTc).
  • Biodistribution, tumor uptake, and imaging studies were performed in xenografted human tumors.
  • The effect of radiometal chelators (MAG(2), DTPA, PEG(3,400)) on biodistribution was assessed.

Related Experiment Videos

Main Results:

  • Fluorescent TTA1 showed rapid perivascular and tumor diffusion.
  • Radiolabeled TTA1 exhibited rapid blood clearance (<2 min half-life) and fast tumor penetration (6% ID/g at 10 min).
  • High tumor-to-blood ratios (50:1 at 3 h) and durable tumor retention were observed, enabling clear imaging of glioblastoma and breast tumors.

Conclusions:

  • TTA1 is effectively taken up by various solid tumors, including breast, glioblastoma, lung, and colon.
  • Rapid tumor uptake and clearance from non-target tissues facilitate clear tumor imaging.
  • Aptamer conjugates show potential for both diagnostic imaging and therapeutic applications in oncology.